Top

Published in:

01-10-2000 | ORIGINAL ARTICLE

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

Authors: Heidi Hörig, David S. Lee, William Conkright, Joe Divito, Henry Hasson, Michelle LaMare, Audrey Rivera, David Park, John Tine, Ken Guito, Kwong Wong-Yok Tsang, Jeffrey Schlom, Howard L. Kaufman

Published in: Cancer Immunology, Immunotherapy | Issue 9/2000

Title: Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule
Authors: Heidi Hörig
David S. Lee
William Conkright
Joe Divito
Henry Hasson
Michelle LaMare
Audrey Rivera
David Park
John Tine
Ken Guito
Kwong Wong-Yok Tsang
Jeffrey Schlom
Howard L. Kaufman
Publication date: 01-10-2000
Publisher: Springer-Verlag
Published in: Cancer Immunology, Immunotherapy / Issue 9/2000
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI: https://doi.org/10.1007/s002620000146

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 9/2000

Erratum: Cancer Immunol Immunother (2000) 49: 314–318

Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas

Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to FcγRI and the epidermal growth factor receptor

Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptides

Expression of acute and late-stage inflammatory antigens, c-fms, CSF-1, and human monocytic serine esterase 1, in tumor-associated macrophages of renal cell carcinomas

Tumor-derived multiple chaperone enrichment by free-solution isoelectric focusing yields potent antitumor vaccines

Keynote webinar | Spotlight on antibody–drug conjugates in cancer